All of us here at ETAP-Lab and STROK@LLIANCE hope all of you are in good health, and wish you every success in all your endeavours, in 2021 and beyond.

our team

As we approach the end of this year unlike any other, we wanted to let you know how ETAP-Lab has managed – and share our plans for 2021 with you.

During the health crisis

Despite two periods of lockdown ETAP-Lab’s activity has not diminished – quite the opposite, in fact! Having ground to an almost complete halt in the spring, the number of research projects entrusted to us has since continued to increase, demonstrating the vitality and resilience of the health innovation sector.

Without ever compromising on quality, our highly-motivated and responsive team has risen to the challenge of reorganisation, allowing us to continue serving you while also ensuring that our employees are protected.

Once again, we would like to thank our customers for the trust they place in us, and our employees for their commitment.

The outlook for 2021  

Despite hopes that a vaccine against COVID-19 will soon be available, it’s clear that some of the changes in how we all work and communicate are here to stay. In addition, much uncertainty remains as to the effects of the health crisis on the global economy.

Nevertheless, positive feedback on 2020 is building confidence in our ability to reinvent ourselves – and armed with this, we are looking to the future with confidence. ETAP-Lab will continue to develop, expanding our range of services. Our many plans include new buildings, fresh scientific collaborations, increasing our in vitro capacity and developing our exports.

2021 looks promising to us!

2020 innovations

The past year has also provided us with a chance to continue our internal research activity, focused on the validation of translational in vitro/in vivo models in our areas of expertise.

  • Neurology
  • Dermatology
    • By validating new reference compounds and routes of administration, we have continued developing our psoriasis model
    • We have also set up a skin grafting model in nude mice

Keep up with our news

We regularly publish news that includes relevant scientific content.

Follow us on LinkedIn: ETAP-Lab and STROK@LLIANCE

STROK@LLIANCE is growing and hiring a new Laboratory Technician – Research Assistant at Caen, FRANCE.

(Caen, FRANCE).

Please find here the job position description.

If you fit to this profile, please contact us at

STROK@LLIANCE s’agrandit et propose un nouveau poste de technicien de laboratoire – assistant de recherche à Caen, FRANCE.

La description du poste est disponible dans ce document 

Si vous êtes intéressés par ce poste, contactez nous à l’adresse suivante:

Created in 2017, the STROK@LLIANCE brand has quickly built a reputation for quality and success in the field of preclinical services in neurology. It is a real pleasure for us to see our brand building value. Having already secured trademark protection in Europe, ETAP-Lab is proud to announce that the Japanese patent office has now [...]
For several years now, Prof. Denis Vivien’s team (Laboratoire PhIND, U1237, Caen), our STROK@LLIANCE partner, has been looking into in the potential of N-Acetylcysteine (NAC, Mucomyst®) for thrombolysis of resistant clots during the acute phase of ischemic stroke. While this old molecule is well known as a bronchial fluidizer, it is not generally thought of [...]
STROK@LLIANCE will participate to MEDICA next 19 November in Dusseldorf. Our expert Dr. Nicolas Violle (CEO) will present Strok@lliance’s services in the field of stroke preclinical research. Our partner CYCERON, represented by Dr. Benoit Haelewyn, will also be present during this event. By taking advantage of the CYCERON facilities, STROK@LLIANCE accesses such cutting-edge technologies as [...]